349 related articles for article (PubMed ID: 8879208)
21. Thrombopoietin augments ex vivo expansion of human cord blood-derived hematopoietic progenitors in combination with stem cell factor and flt3 ligand.
Ohmizono Y; Sakabe H; Kimura T; Tanimukai S; Matsumura T; Miyazaki H; Lyman SD; Sonoda Y
Leukemia; 1997 Apr; 11(4):524-30. PubMed ID: 9096693
[TBL] [Abstract][Full Text] [Related]
22. Gp130 activation by soluble interleukin-6 receptor/interleukin-6 enhances osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells.
Erices A; Conget P; Rojas C; Minguell JJ
Exp Cell Res; 2002 Oct; 280(1):24-32. PubMed ID: 12372336
[TBL] [Abstract][Full Text] [Related]
23. Replating potential of colony-forming units of granulocytes/macrophages (CFU-GM) expanded ex vivo by stem cell factor, interleukin (IL)-3, IL-6, granulocyte colony-stimulating factor, erythropoietin with or without thrombopoietin.
Katayama Y; Takenaka K; Mahmut N; Teshima T; Shinagawa K; Omoto E; Harada M
Int J Hematol; 1998 Aug; 68(2):157-68. PubMed ID: 9803674
[TBL] [Abstract][Full Text] [Related]
24. Thrombopoietin alone stimulates the early proliferation and survival of human erythroid, myeloid and multipotential progenitors in serum-free culture.
Yoshida M; Tsuji K; Ebihara Y; Muraoka K; Tanaka R; Miyazaki H; Nakahata T
Br J Haematol; 1997 Aug; 98(2):254-64. PubMed ID: 9266917
[TBL] [Abstract][Full Text] [Related]
25. Cytokine-dependent ex vivo expansion of early subsets of CD34+ cord blood myeloid progenitors is enhanced by cord blood plasma, but expansion of the more mature subsets of progenitors is favored.
Ruggieri L; Heimfeld S; Broxmeyer HE
Blood Cells; 1994; 20(2-3):436-54. PubMed ID: 7538350
[TBL] [Abstract][Full Text] [Related]
26. Cytokine-induced selective expansion and maturation of erythroid versus myeloid progenitors from purified cord blood precursor cells.
Mayani H; Dragowska W; Lansdorp PM
Blood; 1993 Jun; 81(12):3252-8. PubMed ID: 7685200
[TBL] [Abstract][Full Text] [Related]
27. gp130-stimulating designer cytokine Hyper-interleukin-6 synergizes with murine stroma for long-term survival of primitive human hematopoietic progenitor cells.
Götze KS; Keller U; Rose-John S; Peschel C
Exp Hematol; 2001 Jul; 29(7):822-32. PubMed ID: 11438204
[TBL] [Abstract][Full Text] [Related]
28. The FLT3 ligand is a direct and potent stimulator of the growth of primitive and committed human CD34+ bone marrow progenitor cells in vitro.
Rusten LS; Lyman SD; Veiby OP; Jacobsen SE
Blood; 1996 Feb; 87(4):1317-25. PubMed ID: 8608220
[TBL] [Abstract][Full Text] [Related]
29. I. A bioactive designer cytokine for human hematopoietic progenitor cell expansion.
Fischer M; Goldschmitt J; Peschel C; Brakenhoff JP; Kallen KJ; Wollmer A; Grötzinger J; Rose-John S
Nat Biotechnol; 1997 Feb; 15(2):142-5. PubMed ID: 9035138
[TBL] [Abstract][Full Text] [Related]
30. c-kit is expressed by primitive human hematopoietic cells that give rise to colony-forming cells in stroma-dependent or cytokine-supplemented culture.
Simmons PJ; Aylett GW; Niutta S; To LB; Juttner CA; Ashman LK
Exp Hematol; 1994 Feb; 22(2):157-65. PubMed ID: 7507857
[TBL] [Abstract][Full Text] [Related]
31. Ontogeny-associated changes in the cytokine responses of primitive human haemopoietic cells.
Zandstra PW; Conneally E; Piret JM; Eaves CJ
Br J Haematol; 1998 Jun; 101(4):770-8. PubMed ID: 9674754
[TBL] [Abstract][Full Text] [Related]
32. CD133+ cell selection is an alternative to CD34+ cell selection for ex vivo expansion of hematopoietic stem cells.
Kobari L; Giarratana MC; Pflumio F; Izac B; Coulombel L; Douay L
J Hematother Stem Cell Res; 2001 Apr; 10(2):273-81. PubMed ID: 11359674
[TBL] [Abstract][Full Text] [Related]
33. Effective ex vivo generation of granulopoietic postprogenitor cells from mobilized peripheral blood CD34(+) cells.
Scheding S; Meister B; Bühring HJ; Baum CM; Mc Kearn JP; Bock T; Kanz L; Brugger W
Exp Hematol; 2000 Apr; 28(4):460-70. PubMed ID: 10781904
[TBL] [Abstract][Full Text] [Related]
34. The gp130-stimulating designer cytokine hyper-IL-6 promotes the expansion of human hematopoietic progenitor cells capable to differentiate into functional dendritic cells.
Bernhard H; Lohmann M; Batten WY; Metzger J; Löhr HF; Peschel C; zum Büschenfelde KM; Rose-John S
Exp Hematol; 2000 Apr; 28(4):365-72. PubMed ID: 10781894
[TBL] [Abstract][Full Text] [Related]
35. Haematopoietic action of flt3 ligand on cord blood-derived CD34-positive cells expressing different levels of flt3 or c-kit tyrosine kinase receptor: comparison with stem cell factor.
Sakabe H; Kimura T; Zeng Z; Minamiguchi H; Tsuda S; Yokota S; Hodohara K; Abe T; Lyman SD; Sonoda Y
Eur J Haematol; 1998 May; 60(5):297-306. PubMed ID: 9654159
[TBL] [Abstract][Full Text] [Related]
36. Gestational age changes in circulating CD34+ hematopoietic stem/progenitor cells in fetal cord blood.
Shields LE; Andrews RG
Am J Obstet Gynecol; 1998 May; 178(5):931-7. PubMed ID: 9609562
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of ex vivo expansion potential of cord blood and bone marrow hematopoietic progenitor cells using cell tracking and limiting dilution analysis.
Traycoff CM; Kosak ST; Grigsby S; Srour EF
Blood; 1995 Apr; 85(8):2059-68. PubMed ID: 7536490
[TBL] [Abstract][Full Text] [Related]
38. Serum soluble IL-6 receptor levels during the mobilization of stem cells to peripheral blood.
Omura H; Kawatani T; Tajima F; Ishiga K; Ohmura H; Kawasaki H; Nanba E
Leuk Lymphoma; 2002 Mar; 43(3):623-30. PubMed ID: 12002769
[TBL] [Abstract][Full Text] [Related]
39. Long-term generation of colony-forming cells in liquid culture of CD34+ cord blood cells in the presence of recombinant human stem cell factor.
Migliaccio G; Migliaccio AR; Druzin ML; Giardina PJ; Zsebo KM; Adamson JW
Blood; 1992 May; 79(10):2620-7. PubMed ID: 1375106
[TBL] [Abstract][Full Text] [Related]
40. Serum-free ex vivo expansion of CD34(+) hematopoietic progenitor cells.
Möbest D; Mertelsmann R; Henschler R
Biotechnol Bioeng; 1998 Nov; 60(3):341-7. PubMed ID: 10099437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]